Zymeworks Gross Profit 2016-2022 | ZYME
Zymeworks gross profit from 2016 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Zymeworks Annual Gross Profit
(Millions of US $) |
| 2021 |
$-173 |
| 2020 |
$-132 |
| 2019 |
$-86 |
| 2018 |
$-4 |
| 2017 |
$10 |
| 2016 |
$-26 |
| 2015 |
$-15 |
Zymeworks Quarterly Gross Profit
(Millions of US $) |
| 2022-06-30 |
$-51 |
| 2022-03-31 |
$-61 |
| 2021-12-31 |
$-35 |
| 2021-09-30 |
$-45 |
| 2021-06-30 |
$-49 |
| 2021-03-31 |
$-44 |
| 2020-12-31 |
$-24 |
| 2020-09-30 |
$-52 |
| 2020-06-30 |
$-27 |
| 2020-03-31 |
$-29 |
| 2019-12-31 |
$-44 |
| 2019-09-30 |
$-21 |
| 2019-06-30 |
$-16 |
| 2019-03-31 |
$-6 |
| 2018-12-31 |
$15 |
| 2018-09-30 |
$-12 |
| 2018-06-30 |
$7 |
| 2018-03-31 |
$-13 |
| 2017-12-31 |
$37 |
| 2017-09-30 |
$-11 |
| 2017-06-30 |
$-7 |
| 2017-03-31 |
$-9 |
| 2016-12-31 |
$-7 |
| 2016-09-30 |
$-8 |
| 2016-06-30 |
$-4 |
| 2016-03-31 |
$-8 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.614B |
$0.027B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
